Christie Ballantyne
Christie Ballantyne
確認したメール アドレス:
Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I
M Naghavi, P Libby, E Falk, SW Casscells, S Litovsky, J Rumberger, ...
Circulation 108 (14), 1664-1672, 2003
Biological, clinical and population relevance of 95 loci for blood lipids
TM Teslovich, K Musunuru, AV Smith, AC Edmondson, IM Stylianou, ...
Nature 466 (7307), 707-713, 2010
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial
SE Nissen, SJ Nicholls, I Sipahi, P Libby, JS Raichlen, CM Ballantyne, ...
Jama 295 (13), 1556-1565, 2006
American heart association statistics committee and stroke statistics subcommittee
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Heart disease and stroke statistics-2017 update: a report from the American …, 2017
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)
PH Jones, MH Davidson, EA Stein, HE Bays, JM McKenney, E Miller, ...
The American journal of cardiology 92 (2), 152-160, 2003
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities …
SJ Hwang, CM Ballantyne, AR Sharrett, LC Smith, CE Davis, AM Gotto Jr, ...
Circulation 96 (12), 4219-4225, 1997
Effects of dalcetrapib in patients with a recent acute coronary syndrome
GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ...
New England Journal of Medicine 367 (22), 2089-2099, 2012
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association
M Miller, NJ Stone, C Ballantyne, V Bittner, MH Criqui, HN Ginsberg, ...
Circulation 123 (20), 2292-2333, 2011
The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study
AM McNeill, WD Rosamond, CJ Girman, SH Golden, MI Schmidt, HE East, ...
Diabetes care 28 (2), 385-390, 2005
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events
MS Sabatine, RP Giugliano, SD Wiviott, FJ Raal, DJ Blom, J Robinson, ...
New England Journal of Medicine 372 (16), 1500-1509, 2015
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins AI and B, and HDL density subfractions: The …
AR Sharrett, CM Ballantyne, SA Coady, G Heiss, PD Sorlie, D Catellier, ...
Circulation 104 (10), 1108-1113, 2001
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study
BB Duncan, MI Schmidt, JS Pankow, CM Ballantyne, D Couper, A Vigo, ...
Diabetes 52 (7), 1799-1805, 2003
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association
MA Hlatky, P Greenland, DK Arnett, CM Ballantyne, MH Criqui, ...
Circulation 119 (17), 2408-2416, 2009
Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association
EL Miller, L Murray, L Richards, RD Zorowitz, T Bakas, P Clark, ...
Stroke 41 (10), 2402-2448, 2010
Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study
V Nambi, L Chambless, AR Folsom, M He, Y Hu, T Mosley, K Volcik, ...
Journal of the American College of Cardiology 55 (15), 1600-1607, 2010
T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity
H Wu, S Ghosh, XD Perrard, L Feng, GE Garcia, JL Perrard, JF Sweeney, ...
Circulation 115 (8), 1029, 2007
Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in …
CM Ballantyne, RC Hoogeveen, H Bang, J Coresh, AR Folsom, G Heiss, ...
Circulation 109 (7), 837-842, 2004
Effect of two intensive statin regimens on progression of coronary disease
SJ Nicholls, CM Ballantyne, PJ Barter, MJ Chapman, RM Erbel, P Libby, ...
New England Journal of Medicine 365 (22), 2078-2087, 2011
論文 1–20